FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

40224711000001100: Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Nov 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2078341000001110 Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2078351000001113 Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets Is a Co-codamol 30mg/500mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets Has AMP Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Codeine phosphate true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start